Ajay Bharadwaj

Premium

Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding

Healthcare

29 February, 2024

Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding

Bengaluru-based pharma contract research company Anthem Biosciences Pvt. Ltd, which hit the billion-dollar valuation mark two years ago after private ......

Sreeja Biswas Debjyoti Roy

Premium

True North looks to back former Biocon execs' drug research firm

Healthcare

22 September, 2020

True North looks to back former Biocon execs' drug research firm

Homegrown private equity firm True North is in advanced negotiations to pick up a stake in a pharmaceutical research and ......

Ranjani Raghavan Debjyoti Roy

Recommended for you

Premium

Finance

Quona Capital taps offshore investor in LP-style bet for fourth vehicle

Pro

Infrastructure

Canadian pension fund CPPIB clocks exit from India portfolio

Healthcare

Saudi Arabia's healthcare group Fakeeh Care announces IPO

Premium

Ajay Bharadwaj

Healthcare

Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding

Healthcare

True North looks to back former Biocon execs' drug research firm

Recommended for you

Finance

Quona Capital taps offshore investor in LP-style bet for fourth vehicle

Infrastructure

Canadian pension fund CPPIB clocks exit from India portfolio

Healthcare

Saudi Arabia's healthcare group Fakeeh Care announces IPO

Infrastructure

Realty player Eldeco Group bags follow-on investment from HDFC Capital

Finance

IPO-bound NBFC Northern Arc raises $80 mn from IFC

Finance

RBI bars Kotak Mahindra from taking new clients online due to IT deficiencies